Skip to main content

Calif. Attorney General’s Pelvic Mesh Lawsuit Set In Motion

Calif. Attorney General’s Pelvic Mesh Lawsuit Set In Motion

Calif. Attorney General’s Pelvic Mesh Lawsuit Set In Motion

Introduction

A trial has commenced, against Johnson & Johnson (J&J) and it's subsidiary Ethicon brought by a state attorney general and attorneys for the state of California for allegedly deceiving up to 50,000 California women and hiding the possible painful, lifelong complications caused by using its pelvic mesh devices.

On the first day of the bench trial, California Deputy Attorney General Jinsook Ohta told San Diego County Superior Court Judge Eddie Sturgeon that the defendants lied about the safety of two lines of mesh products: Tension-free Vaginal Tape or TVT, used to treat stress urinary incontinence and Prolift, used to treat pelvic organ prolapse. Judge Ohta also claimed that the polypropylene mesh used in the products could degrade and fray, could be rejected by the patient’s body, could become enmeshed in a lump of scar tissue, and could become “colonized” by bacteria. J&J refused these possible complications and only mentioned the risk of erosion.

The state would be seeking $5,000 in civil penalties for each of J&J’s violations and $2,500 each for violating the state’s False Advertising Law and Unfair Competition Law, as per the judge.

U.S. District Judge Joseph R. Goodwin is presiding overall Ethicon pelvic mesh lawsuits consolidated under multidistrict litigation (MDL No. 2327; In Re: Ethicon, Inc., Pelvic Repair System Products Liability Litigation) in the Southern District of West Virginia.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

NC to Get $150M to Boost Opioid Treatment, Recovery

Categories: Opioids

North Carolina will receive an additional $150 million from Purdue Pharma and the Sackler family as part of a national $7.4 billion settlement related to the opioid

SRI Gets FDA OK for High-Dose Naloxone Trial

Categories: Opioids

SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.

The approval was granted under an Investigational New Drug (IND)…

Spokane County to Get $5M in New Opioid Settlement

Categories: Opioids

Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.

The agreement addresses the company’s role in fueling…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!